CMRX News and Press, Chimerix Inc.

2024-05-01 12:54:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chimerix (NASDAQ: CMRX ) just reported results for the first quarter of 2024. Chimerix reported earnings per share of -25 cents. This was below the analyst estimate for EP...

2024-05-01 11:28:10 ET Chimerix, Inc. (CMRX) Q1 2024 Earnings Conference Call May 1, 2024 8:30 AM ET Company Participants Will O’Connor – Stern Investor Relations Mike Andriole – President and Chief Executive Officer Allen Melemed – Ch...

2024-05-01 07:18:05 ET More on Chimerix Chimerix: Tackling A Strong Unmet Need With Promising Data Chimerix, Inc. (CMRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Chimerix Historical earnings data for Chimerix Financial i...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

– Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026 – – No Dose Limiting Toxicity in ONC206 Phase 1 Studies to Date, Preliminary Phase 1 Safety and Pharmacokinetic (PK) Data...

2024-04-30 11:35:17 ET More on Chimerix Chimerix: Tackling A Strong Unmet Need With Promising Data Seeking Alpha’s Quant Rating on Chimerix Historical earnings data for Chimerix Financial information for Chimerix Read the full article on Seek...

2024-04-30 10:46:05 ET Major earnings expected before the bell on Wednesday include: Ares Capital ( ARCC ) CVS Health ( CVS ) Barrick Gold ( GOLD ) Mastercard ( MA ) Pfizer ( PFE ) Read the full article on Seeking Alpha For further det...

DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio web...

DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 sh...

DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of th...